Trials / Completed
CompletedNCT00795873
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,260 (estimated)
- Sponsor
- ELA Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Post approval study measuring safety outcomes on the Ovatio CRT-D and SITUS OTW LV lead over 5 years.
Conditions
Timeline
- Start date
- 2008-12-01
- First posted
- 2008-11-21
- Last updated
- 2013-09-18
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00795873. Inclusion in this directory is not an endorsement.